What question did this study set out to answer?

To examine the pathophysiological role of platelets in cardiovascular disorders and evaluate recent developments in platelet proteomics for diagnostic and therapeutic applications.

October 9, 2014Translational ProteomicsOpen Access

Platelet proteomics in cardiovascular diseases

Q: What is the clinical evidence from this study?

Study design: Review. Population: Cardiovascular diseases and acute coronary syndromes. Intervention: Platelet proteomics.

View Full Paper

Ask AI

Bookmark

Key result

Platelet proteomics provides an ideal method to discover CVD biomarkers and screen novel antiplatelet agents.

Key Points

To examine the pathophysiological role of platelets in cardiovascular disorders and evaluate recent developments in platelet proteomics for diagnostic and therapeutic applications.
Reviewed biological mechanisms of platelet activation and thrombus formation underlying cardiovascular diseases such as acute coronary syndromes.
Evaluated proteomic approaches tailored to anucleated platelets, focusing on sample preparation standards required for clinical specimens.
Demonstrated that proteomics effectively profiles molecular alterations in anucleated platelets across normal and cardiovascular disease states.
Identified opportunities for proteomic screening to discover biomarkers and design antiplatelet drugs with improved safety profiles.
Emphasized that standardized clinical sample preparation remains essential for generating reproducible platelet proteomic data.

PICO

Population

Cardiovascular diseases and acute coronary syndromes

Intervention / Comparator

Platelet proteomics

Platelet proteomics offers a valuable approach to understanding platelet biology, identifying new biomarkers, and discovering novel antiplatelet agents for cardiovascular diseases.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May advance biomarker and target discovery in cardiovascular disease; leaves open prospective validation before clinical use.

Cite This Study

Vélez et al. (2014) conducted a review in Cardiovascular diseases and acute coronary syndromes. Platelet proteomics was evaluated. Platelet proteomics serves as an ideal method to study platelet biochemistry, identify molecular changes, and screen for new biomarkers and antiplatelet agents in cardiovascular diseases.

synapsesocial.com/papers/6a0b82609ead71e723c1f8bf https://doi.org/10.1016/j.trprot.2014.09.002

View Full Paper

Ask AI

Bookmark

Platelet proteomics in cardiovascular diseases

Key Points

PICO

Discussion

Implication

Cite This Study

Platelet proteomics in cardiovascular diseases

Key Points

PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider